The Maudsley Guidelines on Advanced Prescribing in Psychosis - (The Maudsley Prescribing Guidelines) (Paperback)

About the Book

"The goal for this text is to emphasize that treatment of psychosis must be tailored to the needs of individual patients. While a given diagnosis may suggest principle mechanisms under prescription guidelines, standard treatment of psychosis is unfeasible due to no two patients suffering from an identical illness. This text therefore aims to contrast the one-size-fits-all treatment that general medicine has taken for granted, and instead focuses on building psychiatrist and patient relationships to foster individual treatment plans"--

Book Synopsis

A guide to treating psychosis that provides information on drug options and side-effects in order to allow for weighing treatment options knowledgably

The Maudsley Guidelines on Advanced Prescribing in Psychosis offers a resource that puts the focus on the need to treat the individual needs of a patient. The authors - noted experts on the topic - offer an alternative to the one-size-fits-all treatment of psychosis and shows how to build psychiatrist and patient relationships that will lead to effective individual treatment plans.

The book provides up-to-date data and information about commonly used anti-psychotic drugs and drugs used in bipolar disorder. The text weighs both the upsides and downsides of each pharmaceutical presented, and helps prescribers and patients weigh the costs and benefits of various options to reach an appropriate treatment plan. The authors highlight the treatment at a population level and the systems in which individual treatments take places. This important resource:

• Facilitates the tailoring of an appropriate treatment plan for clients manifesting signs of psychosis
• Offers a comparative strategy that helps gauge the suitability of one treatment plan over another
• Provides at-hand data and information about commonly used anti-psychotic drugs
• Includes an understanding of the origins and side-effects of each drug presented

The Maudsley Guidelines on Advanced Prescribing in Psychosis offers psychiatrists and other mental health practitioners an essential guide for treating psychosis on an individualized level.

From the Back Cover

A guide to treating psychosis that provides information on drug options and side-effects in order to allow for weighing treatment options knowledgably

The Maudsley Guidelines on Advanced Prescribing in Psychosis offers a resource that puts the focus on treating the individual needs of the patient. The authors are noted experts on the topic who offer an alternative to the one-size-fits-all treatment of psychosis and show how to build psychiatrist and patient relationships that will lead to effective individual treatment plans.

The text provides data and guidance about commonly used anti-psychotic drugs and drugs used in bipolar disorder. It provides prescribers and patients with the tools they need to weight the costs and benefits of various treatment options, allowing them to reach an appropriate treatment plan that caters to the patient's specific needs. The authors highlight the treatment at a population level and the systems in which individual treatments take places. This important resource:

• Facilitates the tailoring of an appropriate treatment plan for clients manifesting signs of psychosis
• Offers a comparative strategy that helps gauge the suitability of one treatment plan over another
• Provides at-hand data and information about commonly used anti-psychotic drugs
• Includes an understanding of the origins of side-effects for each drug presented

The Maudsley Guidelines on Advanced Prescribing in Psychosis offers psychiatrists and other mental health practitioners an essential guide for treating psychosis on an individualized level.

About the Author

Paul Morrison, PhD, FRCPsych., is a consultant psychiatrist in Argyll and Bute Hospital, Scotland, UK. He is also an honorary Clinical senior lecturer in psychopharmacology at the Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

David M. Taylor, PhD, FRPharmS, is Director of Pharmacy and Pathology at the Maudsley Hospital and is Professor of Psychopharmacology at King's College London, London, UK.

Phillip McGuire, PhD, is a professor of Psychiatry and Cognitive Neuroscience and head of the Department of Psychosis Studies at the Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.